Poznań University of Physical Education
Poznan, 61-871, Poland
NCT Number: NCT06903195
This study included 8 weeks of supplementation of black chokeberry extract with 18% standardization of the anthocyanins content (dose 2×200 mg per day) or a placebo product made from chokeberry fiber. The first research data was collected among twenty-four homogeneous female swimmers who trained intensively and attended the Sports Championship School Complex. The second research data was collected among a group of twenty-two selective and homogeneous female swimmers who attended the Sports Championship School Complex extensively.
In this study, the athletes were subjected to intensive swimming tests in breaststroke crawl (800m + 200m + 50m) with 15 minutes of active rest between test sections in the water.
Blood samples were taken from the cubital vein at three time points: before stress test (pre-exercise), one minute after the end of the test (post-exercise), and after a 3-hour recovery period (3h recovery). Measurements of morphology, 4-Hydroxynonenal (4-HNE), 8-isoprostane, cortysol, Intestinal fatty acid binding protein (I-FABP), claudin3, lipopolysaccharide (LPS), lipopolysaccharide binding protein (LBP), and levels were determined using ELISA kits (SunRed Biotechnology Company).
Looking for future studies?
Notify Me12 year–16 year
Female
Interventional
Phase 4
Poznan, 61-871, Poland
This study included 8 weeks of supplementation of black chokeberry extract with 18% standardization of the anthocyanins content (dose 2×200 mg per day), or a placebo product made from chokeberry fiber. The first date of research completed the group of twenty-four homogeneous female swimmers, who train swimming intensively and attend the Sports Championship School Complex. The second date of research completed the group of twenty-two selective and homogeneous female swimmers, who train swimming intensively and attend the Sports Championship School Complex.
In this study, the athletes were subjected to intensive swimming tests in breaststroke crawl (800m + 200m + 50m) with 15 minutes of active rest between test sections in the water. Blood samples were taken from the cubital vein at three time points: before stress test (pre-exercise), one minute after the end of the test (post-exercise), and after a 1-hour recovery period (3h recovery).
Measurement: All determined parameters were measured with the available equipment in the ZWKF laboratory in Gorzów Wielkopolski and using commercial assay kits. Measurements were performed by the project contractors.
4-Hydroxynonenal (4-HNE), 8-isoprostane, cortysol, Intestinal fatty acid binding protein (I-FABP), claudin3, lipopolysaccharide (LPS), lipopolysaccharide binding protein (LBP).
(3) The lactate (La) concentration was determined from the capillary blood immediately after collection using a commercially available kit (Dr. Lange, Germany).
A nutritionist thoroughly analyzed the athletes' diets before each exercise test. Using a commercially available program, the amount of energy, protein, carbohydrates, fats, and fiber was then analyzed.
The experiment was conducted in accordance with the Declaration of Helsinki. The Ethical Committee of the Medical University of Poznan approved the study protocol.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Supplement group: supplement of diet - black chokeberry extract (capsules) with 18% standardization of the anthocyanins content (one capsule contained 200 mg). Each capsule also contained: chokeberry fiber, E460b magnesium salts of stearic acid (anti-caking agent), E551 silicon dioxide (anti-caking agent), hydrocypropyl methylcellulose (capsule shell) and E171 titanium dioxide (shell colour).
The producer of all capsules is MLD Biotrade in Poznan.
Placebo group: placebo product - chokeberry fiber (placebo capsules, which were made from chokeberry fiber).
The producer of all capsules is MLD Biotrade in Poznan.
Time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.
Concentration of 4-Hydroxynonenal (4-HNE) [pg/ml]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.
Concentration of 8-isoprostane [ng/mL]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.
Concentration of cortysol [ng/mL]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.
Red blood cell indices: RBC (Red Blood Cells) [106 × µL-1], HGB (Hemoglobin) [g/dL] , HCT (Hematocrit) [%], MCV (Mean Corpuscular Volume)[fl], MCH (Mean Corpuscular Hemoglobin) [pg], MCHC (Mean Corpuscular Hemoglobin Concentration) [g x dL-1] , RDW (Red Blood cells Distribution Width) [%] .
Time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.
was made by placing a drop of blood on a slide and then spreading it with a uniform motion. After drying, it was colored by the May Grunwald-Giemsa method according to the procedure. The stained and fixed smear after drying was viewed under a microscope for quantitative and qualitative assessment.
Time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.
Concentration of I-FABP [pg/ml]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.
Concentration of Claudin3 [ng/ml]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.
Concentration of LPS [EU/l]. ELISA method by the test manufacturer's instructions
Time frame: At rest (before the test), directly after the test, and after a 3-hour recovery period.
Concentration of LBP [ug/ml]. ELISA method by the test manufacturer's instructions
Time frame: Day 1 after overall fast
Prior to the exercise test, the investigators measured the anthropometric parameters, including height (Seca 213 Hamburg, Deutschland) [cm]
Time frame: Day 1 after overall fast
Prior to the exercise test, the investigators measured the anthropometric parameters, including weight (Tanita BC 418 MA, Tanita Corporation, Tokyo, Japan) [kg]
Time frame: Day before the Day 1, in the morning at Day 1
Participants prepared a food record. The results were calculated using the dietetykpro program: energy [kcal]
Time frame: Day before the Day 1, in the morning at Day 1
Participants prepared a food record. The results were calculated using the dietetykpro program: protein [g]
Time frame: Day before the Day 1, in the morning at Day 1
Participants prepared a food record. The results were calculated using the dietetykpro program: carobhydrates [g]
Time frame: Day before the Day 1, in the morning at Day 1
Participants prepared a food record. The results were calculated using the dietetykpro program: fiber [g]
Time frame: Day before the Day 1, in the morning at Day 1
Participants prepared a food record. The results were calculated using the dietetykpro program:: fat [g]
Poznan University of Physical Education
Other
Effect of Chokeberry Supplementation on Oxidative Stress and Gut Microbiota in Swimmers.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06895616
Stress Oxidative
Poznan, Poland
View Trial DetailsNCT04226183
Behavior, Motor Activity
View Trial DetailsNCT07194772
Glucose Homeostasis, Glucose Intolerance
Ottawa, Ontario, Canada
View Trial DetailsNCT07037212
Diabetes Mellitus, Diabetes Mellitus, Type 2
Ankara, Turkey (Türkiye)
View Trial Details